Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 686 results found. Search for [ bharat biotech ]

Results 1 to 21 of 686
BusinessToday.In
April 16, 2021
The Centre is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities.


Rashi Bisaria
New Delhi, April 16, 2021
Apple announces first-ever $200 million carbon removal initiative Cupertino giant Apple on Thursday, April 15, announced a first-of-its-kind carbon removal initiative called 'Restore Fund'. Under this new initiative investments will be made in forestry projects to remove carbon from the atmosphere. The new initiative is part of Apple's broader goal of becoming carbon neutral across its entire value chain by 2 COVID-19 vaccine: Centre permits Mumbai's Haffkine Institute to produce Covaxin...


BusinessToday.In
April 16, 2021
In a letter to Maharashtra Chief Secretary Sitaram Kunte, Renu Swarup, Secretary in Department of Biotechnology, said Haffkine Institute can manufacture the vaccine doses.


PB Jayakumar
April 14, 2021
The company has got permission from the Drug Controller General of India (DCGI) to import the vaccine. Reddy's is also going to tap domestically contract manufactured vaccines as and when companies are allowed to start commercial manufacturing in India


BusinessToday.In
April 14, 2021
Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.


BusinessToday.In
April 13, 2021
The vaccines which are listed in World Health Organization's (WHO) emergency use listing will also be granted emergency use approval in India.


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


BusinessToday.In
April 12, 2021
Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia's Sputnik V may get SEC's nod first


Joe C Mathew
April 11, 2021
India's two approved COVID-19 vaccine makers - Serum Institute of India and Bharat Biotech - are struggling to keep pace with the increasing demand for COVID-19 vaccines within India


BusinessToday.In
April 11, 2021
Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharma companies such as Dr Reddy's Laboratories, Hetero Biopharma, Gland Pharma, Stelis Biopharma and Vichrow Biotech for the production of Sputnik V


Reuters
April 9, 2021
The U.S. drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would \"very shortly apply for permission to conduct clinical bridging trials in India,\" according to the report


BusinessToday.In
April 9, 2021
The move by the national committee on adverse effects following immunisation (AEFI) has come after the European's regulator said it found rare cases of blood clots among some adult recipients who were given AstraZeneca-Oxford university's vaccine shots


PTI
April 9, 2021
A growing number of countries have either halted or limited the use of the AstraZeneca coronavirus vaccine recently over fears that it can cause serious blood clots


PB Jayakumar
April 8, 2021
India had administered 9,01,98,673 vaccine doses till today morning, of which eight states accounted for 60 per cent of the total doses. Maharashtra was leading with 89,49,560 doses, accounting for 9.92 per cent of total doses


Reuters
April 8, 2021
Very timely decision by COFEPRIS to authorize the emergency use of the COVAXIN vaccine manufactured in India. The options for vaccination against COVID-19 in Mexico are expanding, Ebrard said on Twitter


BusinessToday.In
April 6, 2021
Adar says Covishield has found an excellent response below the age of 50 with one dose. About 70 per cent of people are fully protected with one dose, but the second dose is necessary for long-term immunity protection, he adds


BusinessToday.In
April 2, 2021
A subject expert committee (SEC) of the DCGI has allowed Bharat Biotech to give the third dose of Covaxin to a few volunteers six months after the second dose


BusinessToday.In
April 1, 2021
The refusal to grant the certification means that the export of Covaxin to the country would face a delay. It must be mentioned here that a GMP certification is necessary in Brazil for companies looking to sell drugs or vaccines


PTI
March 31, 2021
Union Health Minister Vardhan said, \"More than 61 million vaccine doses have already been administered in our country and 64 million doses have been given to 84 countries under various programmes\"


PAGES 1 OF 35  12345